Gideon Hirshfield, FRCP, PhD: Developing Therapies to Address Pruritus in PBC

Hirschfield describes the need for therapies that address itch in PBC and explains what linerixibat, an IBAT inhibitor, may offer for pruritus.

Read the full article here

Source: www.hcplive.com

Categories: General HCPs, General Medicine News

Tags: TLM24,PBC,pruritus

Tweets with this article

MD Mag

At #TLM24, we spoke with Gideon Hirschfield, FRCP, PhD, about the shortcomings of currently available #PBC treatments when it comes to treating #pruritus and what linerixibat may offer based on phase 3 GLISTEN data. Watch the interview: https://t.co/OzeabwuPuv

AI can be a productivity booster, but workers have to be onboard

AI can improve productivity in a variety of roles but project management software at a company-wide level can present problems. Read more.

Evan Kirstel the $B2B Techfluencer November 27, 2024

Trump taps biotech investor Jim O’Neill for HHS deputy secretary

O’Neill is close with billionaire Peter Thiel and worked on health care in the George W. Bush administration.

STAT November 27, 2024

Markers of positive affect and brain state synchrony discriminate melancholic from non-melancholic depression using naturalistic stimuli

Molecular Psychiatry – Markers of positive affect and brain state synchrony discriminate melancholic from non-melancholic depression using naturalistic stimuli

Sergey Minaev November 27, 2024

Related Articles